September 24, 2019
According to the new research report available at MarketStudyReport.com under the title ‘Global Atrial Fibrillation Devices Market Growth 2019-2024’, the worldwide atrial fibrillation devices market is predicted to accumulate US $4100 million by the year 2024.
Atrial fibrillation (AFib) is the irregularity of heartbeat or arrhythmia that can lead to stroke, heart failure, blood clots and other heart related problems. AFib devices are used for treating atrial fibrillation and includes diagnostic, access, ablation, and visualization products. These devices provide assistance to physicians in treating and diagnosing quivering heart rhythms.
Considering the application spectrum, the market is fragmented as ambulatory surgical centers, clinics, and hospital. While based on the type of surgical procedure, the market is segmented as maze surgery and catheter ablation.
Speaking of the regional outlook, the market is bifurcated into four major regions which are Americas, Middle East & Africa, Asia Pacific, and Europe. North America is presumed to maintain its dominance over the global atrial fibrillation devices market through the forecast period. However, Asia Pacific AFib market is anticipated to record the highest growth rate over the analysis timeframe, due to the presence of a massive patient population, increasing medical tourism and high focus of worldwide industry players on developing Asia Pacific countries like India and China.
As per the report, nearly 4.4% of diagnosed AFib population was treated with ablation technology in Europe, Japan and the United States. Atrial fibrillation population getting ablation treatment is anticipated to increase with a significant rate in these regions. The growing prevalence of atrial fibrillation, and advancement in ablation technologies will stimulate the utilization of ablation products in the upcoming years.
Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1695855/
The worldwide AFib market was worth US $2410 million in 2019 and is projected to record a growth with a CAGR of 9.3% by the year 2024, as per the report. It also presents an inclusive overview, growth opportunities, challenges and trends of atrial fibrillation devices market.
The prominent manufacturers operating in atrial fibrillation devices market include TZ Medical, St. Jude Medical, APT Med, Boston Scientific, Lepu Medical, Biosense Webster, CardioFocus, Medtronic, MicroPort Scientific, Japan Lifeline, Osypka AG, AtriCure, Synaptic Medical, Philips, and Biotronik.